News

New European Bauhaus Facility Survey

Published on | 11 months ago

Programmes Culture and society Climate, Energy, Mobility Agro-Food, Environment Missions New European Bauhaus

The European Commission has launched a survey for the New European Bauhaus (NEB) Facility for interested parties to contribute to the content of this initiative. The NEB Facility, established in the Horizon Europe 2025-27 Strategic Plan, covers the full cycle of implementation of solutions for neighbourhoods by combining two components: a Research and Innovation part funded by around €120 million per year through Horizon Europe and a roll-out part, with a similar budget ambition as the R&I component, delivered through investments across different EU programmes.

The survey is still open until 17 September 2024.

More information on the New European Bauhaus Facility can be found in this scoping document.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1641 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.